ZA929826B - Inhibitors of 5-alpha-testosterone reductase. - Google Patents

Inhibitors of 5-alpha-testosterone reductase.

Info

Publication number
ZA929826B
ZA929826B ZA929826A ZA929826A ZA929826B ZA 929826 B ZA929826 B ZA 929826B ZA 929826 A ZA929826 A ZA 929826A ZA 929826 A ZA929826 A ZA 929826A ZA 929826 B ZA929826 B ZA 929826B
Authority
ZA
South Africa
Prior art keywords
inhibitors
alpha
testosterone reductase
testosterone
reductase
Prior art date
Application number
ZA929826A
Inventor
Stephen Vernon Frye
Cynthia Market Cribbs
Patrick Reed Maloney
Robert Carl Andrews
Curt Dale Haffner
Original Assignee
Glaxo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Inc filed Critical Glaxo Inc
Publication of ZA929826B publication Critical patent/ZA929826B/en

Links

ZA929826A 1991-12-20 1992-12-18 Inhibitors of 5-alpha-testosterone reductase. ZA929826B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81225791A 1991-12-20 1991-12-20

Publications (1)

Publication Number Publication Date
ZA929826B true ZA929826B (en) 1993-09-08

Family

ID=25209026

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA929826A ZA929826B (en) 1991-12-20 1992-12-18 Inhibitors of 5-alpha-testosterone reductase.

Country Status (1)

Country Link
ZA (1) ZA929826B (en)

Similar Documents

Publication Publication Date Title
JPS6426535A (en) Novel hmg-coa reductase inhibitor
AU2067892A (en) Corrosion inhibitors
SG46381A1 (en) Leukoriene biiosynthese inhibitor
EP0601322A3 (en) Adenosindeaminase inhibitor.
IL108075A0 (en) Enzyme inhibitors
ZA929642B (en) Stabilized pharmaceutical compositions comprising an HMG-CoA reductase inhibitor compound.
ZA917096B (en) Enzyme inhibitors
HU9400952D0 (en) Heteroaryl-amines as acetyl-cholinesterase inhibitors
EP0612249A4 (en) Methods of inhibiting restenosis.
EP0529854A3 (en) Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as hmg-coa reductase inhibitors
AU648907B2 (en) Corrosion inhibitors
EP0251625A3 (en) Novel hmg-coa reductase inhibitors
EP0630245A4 (en) Protein kinase c inhibitor.
EP0462661A3 (en) Novel 17beta-hydroxybenzoyl-4-aza-5alpha-androst-1-en-3-ones as testosterone reductase inhibitors
EP0403487A4 (en) Novel hmg-coa reductase inhibitors
EP0323866A3 (en) Novel hmg-coa reductase inhibitors
ZA886468B (en) Novel hmg-coa reductase inhibitors
AU1797392A (en) Pla2 inhibitors
JPS6463595A (en) Ribonucleotide reductase inhibitor
AU8769291A (en) Deoxyhypusyl hydroxylase inhibitors
ZA934970B (en) Enzyme inhibitors
EP0639075A4 (en) Specific inhibition of dihydrofolate reductase and compounds therefor.
GB9303051D0 (en) 17b-nmonosubstituted carbamoyl-11-oxo-4-aza-5-a-androst-en-3-one testosterone-5-alpha reductase inhibitors
ZA929826B (en) Inhibitors of 5-alpha-testosterone reductase.
ZA939480B (en) Enzyme inhibitor